Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 13, 2022 02:00 ET | Source: QuantuMDx Group Ltd

QuantuMDx receives CDTA approval for sale of Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay

QuantuMDx receives CDTA approval for sale of Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay NEWCASTLE UPON TYNE, UK 13 December, 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its...
August 16, 2021 02:00 ET | Source: QuantuMDx Group Ltd

QuantuMDx partners with Cignpost Diagnostics

QuantuMDx partners with Cignpost Diagnostics Providing a rapid, PCR COVID-19 testing solution to the UK film & TV industry NEWCASTLE UPON TYNE, UK, 16 August 2021. QuantuMDx Group Limited has...
July 09, 2021 02:00 ET | Source: QuantuMDx Group Ltd

QuantuMDx launches Q-POC™ - rapid PCR point of care diagnostic system

QuantuMDx launches Q-POC™ - rapid PCR point of care diagnostic system Roll out at ECCMID 2021 with Q-POC™ SARS-CoV-2 assay96.9% sensitivity, 98.3% specificitySample to result - approximately 30...
February 13, 2021 10:30 ET | Source: QuantuMDx Group Ltd

Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx

Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx - QuantuMDx has developed Q-POC™ - a rapid, PCR diagnostic device for coronavirus testing at the point of...
April 17, 2019 02:00 ET | Source: QuantuMDx Group Ltd

QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be evaluated by GlaxoSmithKline’s C&GT platform group.

Press Release: 17 April 2019 QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies...